Adverse drug reactions account for an estimated 6-7% of all veterinary hospital admissions, with drug interactions representing a significant and preventable subset. Many of these interactions involve commonly prescribed drugs used in routine practice. Use the Drug Formulary for interaction checking and the Pharmacology Specialist for complex polypharmacy guidance.
Mechanism: Combined COX-1 and COX-2 inhibition dramatically increases risk of gastrointestinal ulceration, perforation, and renal injury. Protective prostaglandins in the GI mucosa and renal medulla are maximally suppressed.
Clinical scenario: Owner gives over-the-counter ibuprofen or aspirin to a dog already receiving carprofen or meloxicam. Or a veterinarian switches NSAIDs without adequate washout period.
Outcome: GI hemorrhage, melena, vomiting, acute renal failure. Gastric perforation carries a mortality rate of 50-70%.
Prevention: Always ask about all medications including OTC products. Minimum 5-7 day washout between different NSAIDs. Educate clients that human NSAIDs are dangerous for pets.
Mechanism: Corticosteroids inhibit phospholipase A2, reducing protective prostaglandin synthesis via a different pathway than NSAIDs. Concurrent use amplifies GI ulceration risk by 5-10x compared to either agent alone.
Clinical scenario: A dog on chronic prednisone for immune-mediated disease is prescribed an NSAID for concurrent osteoarthritis pain. Or a prednisone taper is not completed before an NSAID is started.
Outcome: Severe GI ulceration and hemorrhage. The combination is the most common cause of clinically significant GI bleeding in dogs.
Prevention: Never combine. Washout of at least 5-7 days when switching between drug classes. If a patient on corticosteroids needs analgesia, use opioids, gabapentin, or acetaminophen (dogs only, 10-15 mg/kg q12h) as alternatives.
Mechanism: Tramadol inhibits serotonin reuptake. Combined with SSRIs (fluoxetine) or TCAs (clomipramine), serotonin accumulates to toxic levels in the CNS.
Clinical signs: Agitation, hyperthermia, tremors, myoclonus, tachycardia, diarrhea, seizures. Severe cases can be fatal.
Clinical scenario: A dog on fluoxetine for anxiety is prescribed tramadol for post-operative pain.
Prevention: Avoid tramadol in patients on any serotonergic medication. Use opioids (buprenorphine, hydromorphone) or gabapentin for analgesia instead.
| Drug Combination | Mechanism of Harm | Clinical Effect | Alternative |
|---|---|---|---|
| Fluoroquinolone + Theophylline | FQ inhibits CYP1A2, increasing theophylline levels | Theophylline toxicity: seizures, cardiac arrhythmias | Use doxycycline or reduce theophylline dose 30-50% |
| Metronidazole + Phenobarbital | Phenobarbital induces CYP3A4, reducing metronidazole levels; metronidazole neurotoxicity risk additive | Subtherapeutic metronidazole or increased CNS toxicity | Use amoxicillin-clavulanate for anaerobic coverage |
| ACE inhibitor + K-sparing diuretic | Both reduce potassium excretion | Life-threatening hyperkalemia; cardiac arrhythmias, bradycardia | Monitor K+ closely; avoid spironolactone in renal failure |
| Cisapride + Azole antifungal | Azoles inhibit CYP3A4, increasing cisapride levels | QT prolongation, ventricular arrhythmias, sudden death | Use metoclopramide; avoid concurrent azoles |
Warning: Spironolactone is increasingly used in Stage C CHF alongside ACE inhibitors (enalapril, benazepril). While this combination is accepted in cardiology, it requires regular monitoring of serum potassium (every 1-2 weeks initially, then every 3-6 months). Hyperkalemia risk is highest in patients with concurrent renal disease.
8. Doxycycline + Antacids/Iron/Sucralfate: Divalent and trivalent cations (Ca, Mg, Al, Fe) chelate tetracyclines, reducing oral bioavailability by up to 80%. Separate administration by at least 2 hours. This is particularly relevant for patients on sucralfate for GI protection who also need doxycycline for infections.
9. Cyclosporine + Ketoconazole: This is an intentional interaction used therapeutically: ketoconazole inhibits CYP3A4 and P-glycoprotein, increasing cyclosporine levels and allowing dose reduction (and cost savings). However, the interaction is unpredictable and variable between patients. Requires cyclosporine level monitoring. Too much inhibition leads to nephrotoxicity and hepatotoxicity.
10. Aminoglycoside + Furosemide: Both agents are independently nephrotoxic and ototoxic. Combined use amplifies risk through synergistic damage to renal tubular cells and cochlear hair cells. In critically ill patients requiring both agents (e.g., sepsis with fluid overload), monitor renal values daily, minimize aminoglycoside duration, and consider therapeutic drug monitoring.
Develop a systematic approach to drug interaction prevention: maintain a complete medication history for every patient (including supplements, OTC products, and products from other veterinarians), review for interactions before prescribing any new medication, use drug interaction databases and the Drug Formulary when prescribing polypharmacy regimens, educate clients about the dangers of sharing medications between pets or giving human medications, and flag high-risk patients (renal disease, hepatic disease, cardiac patients on multiple drugs) for pharmacokinetic monitoring.
When in doubt about a drug combination, consult the Pharmacology Specialist for evidence-based guidance on interaction severity and management strategies.
- NSAID + NSAID and NSAID + corticosteroid are the most common and dangerous drug interactions in veterinary practice; never combine, and observe 5-7 day washout periods.
- Serotonin syndrome from tramadol + SSRI combinations is life-threatening; use opioids or gabapentin for analgesia in patients on serotonergic drugs.
- Doxycycline absorption is reduced up to 80% by antacids, sucralfate, and iron; separate dosing by 2+ hours.
- ACE inhibitor + spironolactone requires regular potassium monitoring, especially in patients with renal compromise.
- Aminoglycoside + furosemide carries synergistic nephrotoxicity and ototoxicity; monitor renal values daily when concurrent use is unavoidable.
- A complete medication history, including OTC and supplements, is essential before prescribing any new drug.